Document is current
Any future updates will be listed below
-
Authors
Thomson, Pippa A
Duff, Barbara
Blackwood, Douglas H R
Romaniuk, Liana
Watson, Andrew
Whalley, Heather C
Li, Xiang
Dauvermann, Maria R
Moorhead, T William J
Bois, Catherine
Ryan, Niamh M
Redpath, Holly
Hall, Lynsey
Morris, Stewart W
van Beek, Edwin J R
Roberts, Neil
Porteous, David J
St. Clair, David
Whitcher, Brandon
Dunlop, John
Brandon, Nicholas J
Hughes, Zoë A
Hall, Jeremy
McIntosh, Andrew
Lawrie, Stephen M
- License Information
-
More Information
Article History
Received: 18 April 2016
Revised: 30 June 2016
Accepted: 1 July 2016
First Online: 10 August 2016
Competing interests
: S.M.L. has received financial support for research from Roche and Abbvie in relation to therapeutic studies of people with schizophrenia. He has also received personal payment for input into educational initiatives from Roche, Janssen, and Sunovion. These received funds do not present a conflict of interest with the present study. B.W., J.D., N.J.B., and Z.A.H. are all current or former employees of Pfizer. J.D. and N.J.B. are current employees of AstraZeneca. The remaining authors declare no conflict of interest.
